Results 41 to 50 of about 1,105,809 (304)

Central Nervous System Tumors Among Infants in Canada: A Report From CYP‐C

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Central nervous system (CNS) tumors in infants are rare, pose unique clinical challenges, and lack large‐scale evidence‐based data to guide management. This study seeks to describe CNS tumors in Canadian infants and to compare their outcomes with those of older children.
Samuel Sassine, Hallie Coltin, Sylvia Cheng, Lucie Lafay‐Cousin, Vanan Issai Magimairajan, Craig Erker, Stéphanie Vairy, Lynette Bowes, Adam Fleming, Donna Johnston, Sarah McKillop, Roona Sinha, Julie Bennett, Christina Coleman, Laura Wheaton, Shayna Zelcer, Samuele Renzi, Thai Hoa Tran   +17 more
wiley   +1 more source

Complementary and alternative medicine use by pediatric oncology patients before, during, and after treatment

BMC Complementary Medicine and Therapies, 2021
Background The prevalence of complementary and alternative medicine (CAM) use and the modalities used by pediatric oncology patients vary widely across studies.
Emmanuelle Lüthi, Manuel Diezi, Nadia Danon, Julie Dubois, Jérôme Pasquier, Bernard Burnand, Pierre-Yves Rodondi   +6 more
doaj   +1 more source

Side Effects With a Focus on Lymphadenopathy Following COVID-19 Vaccination in Pediatric and AYA Oncology Patients [PDF]

, 2023
The Coronavirus Disease 2019 (COVID-19) pandemic led to the swift development of multiple vaccinations. Vaccine side effects were well-documented in the healthy adult cohort and included fever and lymphadenopathy, however, side effects in the pediatric ...
Guang Xu, Belsky, Jennifer A., Seethal A. Jacob, Carroll, Whitney R., Xu, Guang, Whitney R. Carroll, Jacob, Seethal A., Jennifer A. Belsky   +7 more
core   +1 more source

Comparative Drug Response Profiling in Neuroblastoma Cell Lines and Patient‐Derived Tumor Organoids

Pediatric Blood &Cancer, EarlyView.
ABSTRACT High‐risk neuroblastoma remains a leading cause of pediatric cancer mortality, and improved preclinical models are needed to guide therapeutic developments. We screened seven high‐risk neuroblastoma cell lines and three patient‐derived tumor organoids with 528 compounds alongside bone marrow controls, and compared them with external datasets ...
Krzysztof Wierbiłowicz, Se Whee Sammy Park, Aironas Los, Ernest Liu, Nona Struyf, Tom Erkers, Sören Lehmann, Jan J. Molenaar, Jakob Stenman, Olli Kallioniemi, Päivi Östling, Brinton Seashore‐Ludlow, Kasper Karlsson   +12 more
wiley   +1 more source

Offering a Concert for Two: An Interpretation of Friendship in Pediatric Oncology Palliative Care Nursing

Journal of Applied Hermeneutics, 2018
In this paper, written for a hermeneutic research course for my master's graduate work, I discuss how pediatric oncology nursing is an interpretive practice. I explore the subject of the relational complexity of pediatric oncology nursing, conceptualized
Katie M. Webber
doaj   +1 more source

Tolerability of topotecan in refractory metastatic neuroblastoma after autologous haematopoietic stem cell transplantation (auto-HSCT)

, 1998
link_to_subscribed_fulltext30th Meeting of International Society of Pediatric Oncology (SIOP), Yokohama, Japan, 4-8 October 1998. In Medical and Pediatric Oncology, 1998, v. 31 n. 4, p. 342, abstract no.
Tam, PKH, Chiu, DCK, Lau, YL, Chan, GCF, Cheng, W, Chan, KL, Ha, SY, Kwong, DLW   +7 more
core   +2 more sources

Factors Influencing Pediatric Hematology/Oncology Nurse Retention: A Scoping Review

, 2022
Background: Nursing staff retention is an ongoing concern within pediatric hematology/oncology settings globally. Work-related stressors cause emotional burden, psychological distress, and burnout to which nurses respond by leaving their workplace ...
Macintyre, MR, Schults, JA, Brown, BWJ, Jessica A. Schults, Brandon W. J. Brown, Madeleine R. Macintyre   +5 more
core   +1 more source

Impact of Radiation Therapy on Physical and Psychosocial Health of Adolescents and Young Adults: A Joint Report From the Children's Oncology Group AYA and Radiation Oncology Committees

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Rates of cancer among adolescents and young adults (AYA), age 15–39 years, are increasing. Consequently, radiation oncologists are treating more AYAs who have diagnoses spanning both pediatric and adult practices. Compared to pediatric and older adult patients, AYAs face a unique set of challenges.
Hesham Elhalawani, Rachel K. Peterson, Avani D. Rao, Laurie J. McKenzie, Ahmed Magdy Elmotayam, Leslie Chang, Michael Roth, Susan L. McGovern   +7 more
wiley   +1 more source

Social Functioning Within the First Years After Pediatric Brain Tumor Diagnosis and the Relationship With Family Psychosocial Risk

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Survivors of pediatric brain tumors (PBTs) can experience long‐term social difficulties, impacting quality of life. Beyond medical and environmental factors, family psychosocial risk may play a role in social outcomes by shaping the caregiving environment and may provide intervention options.
Renske H. Houben, Marisa H. Huisman, Martha A. Grootenhuis, Femke K. Aarsen, Marita Partanen   +4 more
wiley   +1 more source

Pediatric hematology and oncology physician and nurse practitioner views of the HPV vaccine and barriers to administration

Human Vaccines & Immunotherapeutics, 2023
Rates of Human papilloma virus (HPV) vaccination among pediatric survivors of cancer and patients with sickle cell disease are lower than the national average. While recent attention has focused on patient HPV vaccine hesitancy and refusal, less is known
Meagan E. Miller, Mahvish Q. Rahim, Scott L. Coven, Seethal A. Jacob, Gregory D. Zimet, Carolyn G. Meagher, Mary A. Ott   +6 more
doaj   +1 more source